IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,778,549 | -15.9% | 2,943,710 | -2.8% | 4.09% | -5.3% |
| Q2 2023 | $181,583,464 | +22.4% | 3,028,410 | +0.9% | 4.32% | +22.0% |
| Q1 2023 | $148,402,169 | -21.7% | 3,001,662 | -9.6% | 3.54% | -22.4% |
| Q4 2022 | $189,533,237 | +15.6% | 3,321,066 | -4.9% | 4.56% | +7.7% |
| Q3 2022 | $163,996,000 | +64.5% | 3,493,743 | +30.8% | 4.24% | +46.0% |
| Q2 2022 | $99,679,000 | +30.6% | 2,671,652 | +4.7% | 2.90% | +51.0% |
| Q1 2022 | $76,306,000 | -9.8% | 2,552,034 | +3.3% | 1.92% | -1.7% |
| Q4 2021 | $84,626,000 | -6.6% | 2,471,555 | +1.1% | 1.96% | +2.6% |
| Q3 2021 | $90,642,000 | -3.1% | 2,445,155 | +2.1% | 1.91% | +3.1% |
| Q2 2021 | $93,517,000 | -4.2% | 2,394,785 | +4.5% | 1.85% | -13.2% |
| Q1 2021 | $97,583,000 | – | 2,292,285 | – | 2.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |